Skip to content

The therapeutic effect of Bushen Huoxue Recipe on Premature Ovarian Insufficiency: a prospective, randomized, double-blind, controlled clinical research

The therapeutic effect of Bushen Huoxue Recipe on Premature Ovarian Insufficiency: a prospective, randomized, double-blind, controlled clinical research

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037572
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Insufficiency

Interventions

Sponsors

Yueyang hospital of Integrated Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Normally developed women aged 18-40 years; (2) Meet the above-mentioned Western medical diagnostic criteria and the syndrome differentiation criteria of irregular menstruation and kidney deficiency; (3) Did not receive hormone therapy 3 months before enrollment; (4) Those who are willing to participate in this study and sign an informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients who are in the acute inflammatory phase or who use radiotherapy and chemotherapy drugs for tumor diseases; (2) Accompanied by organic diseases such as genital malformations and hypogonadism; (3) Patients with a history of bilateral ovarian resection; (4) People with serious primary diseases such as diabetes, cardiovascular, lung, liver, kidney and hematopoietic system, or other serious diseases that affect fertility; (5) People with mental illnesses such as psychosis, epilepsy and neurosis; (6) Those who are allergic or severely allergic to the test drug; (7) Patients in pregnancy; (8) Those who are participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
FSH;

Secondary

MeasureTime frame
LH;E2;AMH;FSHR;INH;ACT;FS;ANA;AOA;ACA;miRNA-23a;

Countries

China

Contacts

Public ContactXia Yanqiu

Yueyang hospital of Integrated Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine

cclarisse@163.com+86 18621837502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026